BackJohnson & Johnson Overview

Johnson & Johnson Accounts Payable

Track Johnson & Johnson's accounts payable ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00
↓ 100.00% YoYΔ $-9.63B vs prior year quarter

Peer trimmed avg / median

Loading

Johnson & Johnson Accounts Payable History

Loading

Johnson & Johnson vs. peers: Accounts Payable Comparison

Loading

Johnson & Johnson Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Johnson & Johnson (JNJ) FAQ

As of the most recent data (September 2026), JNJ shows a accounts payable of $0. That compares with $9.6B in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JNJ's accounts payable is now $0 (was $9.6B) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Johnson & Johnson is outperforming or lagging.

Tracking JNJ's accounts payable over time shows whether Johnson & Johnson is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $9.6B in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Johnson & Johnson's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $0) with ownership activity and broader fundamentals.

Johnson & Johnson's accounts payable is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.